Guidance

Clinical guidelines for immunoglobulin use (second edition update)

The Clinical Guidelines for Immunoglobulin Use, implemented in 2008, are to ensure best practice in the use of immunoglobulin across all indications.

Documents

Download Clinical Guidelines for Immunoglobulin Use: Second Edition Update (updated 15 November 2011)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Download Clinical Guidelines for Immunoglobulin Use: Second Edition

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

The guidelines were developed utilising an evidence review and extensive consultations with clinicians and other stakeholders. This Update fulfils the commitment made in the Second Edition to undertake a biennial review from 2009. The Second Edition Guidelines remain in place, and this Update should be used in conjunction with them.

The Clinical Guidelines support the DH-initiated National Demand Management Programme for Immunoglobulin to provide guidance on appropriate use, to manage demand and to ensure supply for patients for whom immunoglobulin is life-saving.

Arrangements for future immunoglobulin guideline reviews, in the context of the changes in the wider NHS, are currently under discussion. We will give notification of future arrangements in due course.